Thomas O Daniel insider trades
Open-market stock purchases and sales by Thomas O Daniel, Director at Gossamer Bio, Inc, from SEC Form 4 filings since Mar 1, 2012.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
Companies traded
- GOSS Gossamer Bio, Inc: other filings, last Jun 4, 2026
- MGTA Magenta Therapeutics, Inc: other filings, last Jun 28, 2022
- LRMR Larimar Therapeutics, Inc: other filings, last May 12, 2021
- ZFGN Zafgen, Inc: other filings, last Jun 26, 2019
- JUNO Juno Therapeutics, Inc: other filings, last Mar 5, 2018
- CELG Celgene Corp /de/: 8 sales, last Dec 17, 2015